Skip to main content
. 2018 Sep 26;9:2216. doi: 10.3389/fimmu.2018.02216

Figure 5.

Figure 5

Schematic diagram of activated immune cell-mediated liver damage after OLT and ceruloplasmin could effectively alleviate the liver rejection via modulating the redox imbalance.